גמסיטאבין PCH טבע ® 200 מ"ג /ויאל Israeli - Kiebrania - Ministry of Health

גמסיטאבין pch טבע ® 200 מ"ג /ויאל

abic marketing ltd - gemcitabine as hydrochloride 200 mg - powder for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer.gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage.breast cancer:gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated.ovarian cancer:gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

גמסיטאבין PCH טבע ® 2000 מ"ג /ויאל Israeli - Kiebrania - Ministry of Health

גמסיטאבין pch טבע ® 2000 מ"ג /ויאל

abic marketing ltd - gemcitabine as hydrochloride 2000 mg - powder for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

טרסבה 150 מג Israeli - Kiebrania - Ministry of Health

טרסבה 150 מג

roche pharmaceuticals (israel) ltd - erlotinib as dihydrochloride - טבליות מצופות פילם - erlotinib as dihydrochloride 150 mg - erlotinib - erlotinib - tarceva is indicated for the treatment of patients with locally advanced or metastatic non - small cell lung cancer after failure of at least one prior chemotherapy regimen. tarceva is indicated in combination with gemcitabine for the first-line treatment of patients with locally advanced unresectable or metastatic pancreatic cancer.tarceva® monotherapy is indicated for the maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. tarceva is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with egfr activating mutations.

טרסבה 100 מג Israeli - Kiebrania - Ministry of Health

טרסבה 100 מג

roche pharmaceuticals (israel) ltd - erlotinib as dihydrochloride - טבליות מצופות פילם - erlotinib as dihydrochloride 100 mg - erlotinib - erlotinib - tarceva is indicated for the treatment of patients with locally advanced or metastatic non - small cell lung cancer after failure of at least one prior chemotherapy regimen. tarceva is indicated in combination with gemcitabine for the first-line treatment of patients with locally advanced unresectable or metastatic pancreatic cancer.tarceva® monotherapy is indicated for the maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. tarceva is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with egfr activating mutations.

ארלוטיניב אס.קיי. 150 מג Israeli - Kiebrania - Ministry of Health

ארלוטיניב אס.קיי. 150 מג

k.s.kim international (sk- pharma) ltd., israel - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 150 mg - erlotinib

ארלוטיניב טבע 100 מג Israeli - Kiebrania - Ministry of Health

ארלוטיניב טבע 100 מג

teva israel ltd - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 100 mg - erlotinib

ארלוטיניב טבע 150 מג Israeli - Kiebrania - Ministry of Health

ארלוטיניב טבע 150 מג

teva israel ltd - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 150 mg - erlotinib

ארלוטיניב תרו 100 מג Israeli - Kiebrania - Ministry of Health

ארלוטיניב תרו 100 מג

taro international ltd, israel - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 100 mg - erlotinib

ארלוטיניב תרו 150 מג Israeli - Kiebrania - Ministry of Health

ארלוטיניב תרו 150 מג

taro international ltd, israel - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 150 mg - erlotinib

ארלוטיניב תרו 25 מג Israeli - Kiebrania - Ministry of Health

ארלוטיניב תרו 25 מג

taro international ltd, israel - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 25 mg - erlotinib